Nickel(II) sulfate hexa-/ heptahydrate

Name: Nickel(II) sulfate hexa-/ heptahydrate
Brand: ALDRICH

DIN 50970 H, ≥20.6% Ni and Co basis

ログインで組織・契約価格をご覧ください。

サイズを選択してください

この商品について

化学式:

NiSO₄ · 6-7H₂O

CAS番号:

15244-37-8

分子量:

154.76 (anhydrous basis)

NACRES:

NA.23

PubChem Substance ID:

57647108

UNSPSC Code:

12352302

EC Number:

232-104-9

MDL number:

MFCD00011146

Form:

powder or crystals

主要文書

すべての文書を表示

テクニカルサービス

お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。

お手伝いします

テクニカルサービス

お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。

お手伝いします

InChI key

LGQLOGILCSXPEA-UHFFFAOYSA-L

InChI

1S/Ni.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2

SMILES string

[Ni++].[O-]S([O-])(=O)=O

agency

DIN 50970 H

form

powder or crystals

composition

Ni and Co, ≥20.6%

reaction suitability

core: nickel, reagent type: catalyst
core: nickel

impurities

≤0.05% insoluble in H₂SO₄

pH

≥3.5 (20 °C, 20%)

cation traces

As: ≤10 mg/kg, Cd: ≤50 mg/kg, Co: ≤5000 mg/kg, Cu: ≤20 mg/kg, Fe: ≤50 mg/kg, Pb: ≤20 mg/kg, Zn: ≤50 mg/kg

application(s)

battery manufacturing
battery precursors
catalysts
material synthesis precursor

Quality Level

100

pictograms

GHS08,GHS07,GHS09

signalword

Danger

hcodes

H302 + H332,H315,H317,H334,H351,H360,H372,H410

pcodes

P202 - P273 - P280 - P301 + P312 - P302 + P352 - P308 + P313

Hazard Classifications

Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Repr. 1B - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1 Inhalation

保管分類

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Specified Class I Designated Chemical Substances

prtr

Substances Subject to be Indicated Names

ishl_indicated

Substances Subject to be Notified Names

ishl_notified

13635-1KG-R:4548173307145 + 13635-50KG-R: + 13635-6X2.5KG-R: + 13635-6X1KG-R: + 13635-BULK-R: + 13635-2.5KG-R:4548173307152 + 13635-VAR-R: + 13635-50KG-H:

jan

最新バージョンのいずれかを選択してください：

試験成績書（COA）

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

COAを検索

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate.

L Curto et al.

Journal of the European Academy of Dermatology and Venereology : JEADV, 28(10), 1356-1362 (2014-03-13)

Topical corticosteroids (TC) consistently show effectiveness against itch, a paradigmatic symptom, in various eczemas. Rapid itch relief is a therapeutic goal. The early response of itch to TC has not been adequately studied. To assess the effect on itch of

Performance of a novel in vitro assay for skin sensitization based on activation of T lymphocytes.

Fenxia Hou et al.

ALTEX, 37(3), 451-468 (2020-04-24)

There are currently no skin sensitization assays based on T cell activation. We built a novel in vitro model to assess T cell activation and test its performance to discriminate skin sensitizers from non-sensitizers using 52 reference chemicals. Jurkat Clone

Positive nickel patch tests in infants are of low clinical relevance and rarely reproducible.

Charlotte G Mortz et al.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 24(1), 84-87 (2013-01-22)

We have previously reported patch test reactivity to nickel sulphate in a cohort of unselected infants tested repeatedly at 3-18 months of age. A reproducible positive reaction at 12 and 18 months was selected as a sign of nickel sensitivity provided a

A parallel diffusion-based microfluidic device for bacterial chemotaxis analysis.

Guangwei Si et al.

Lab on a chip, 12(7), 1389-1394 (2012-03-01)

We developed a multiple-channel microfluidic device for bacterial chemotaxis detection. Some characteristics such as easy operation, parallel sample adding design and fast result readout make this device convenient for most biology labs. The characteristic feature of the design is the

Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma.

Svetlana Paskaš et al.

Molecular carcinogenesis, 58(8), 1362-1375 (2019-04-19)

The main focus of this study is exploring the effect and mechanism of two HIV-protease inhibitors: Ritonavir and Ritonavir-nitric oxide (Ritonavir-NO) on in vitro growth of melanoma cell lines. NO modification significantly improved the antitumor potential of Ritonavir, as the

Nickel(II) sulfate hexa-/ heptahydrate

DIN 50970 H, ≥20.6% Ni and Co basis

サイズを選択してください

この商品について

主要文書

特性

InChI key

InChI

SMILES string

agency

form

composition

reaction suitability

impurities

pH

cation traces

application(s)

Quality Level

関連するカテゴリー

安全性情報

pictograms

signalword

hcodes

pcodes

Hazard Classifications

保管分類

wgk

flash_point_f

flash_point_c

ppe

適用法令

Specified Class I Designated Chemical Substances

Substances Subject to be Indicated Names

Substances Subject to be Notified Names

13635-1KG-R:4548173307145 + 13635-50KG-R: + 13635-6X2.5KG-R: + 13635-6X1KG-R: + 13635-BULK-R: + 13635-2.5KG-R:4548173307152 + 13635-VAR-R: + 13635-50KG-H:

資料

試験成績書（COA）

以前この製品を購入いただいたことがある場合

参考文献

テクニカルサービス